Phosphogliv

a hepatoprotective agent

Networked: 10 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Pharmaceutical Preparations
- Drug Combinations: 5337
  - Phosphogliv: 10
Lipids: 114793
- Membrane Lipids: 1591
  - Phospholipids: 11903
    - Glycerophosphates: 118
      - Phosphatidic Acids: 358
        Glycerophospholipids: 689
        Phosphatidylcholines: 2371
        Phosphogliv: 10
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Terpenes: 1461
    - Triterpenes: 2493
      - Pentacyclic Triterpenes: 108
        Glycyrrhizic Acid: 1041
        Phosphogliv: 10

Experts

1.	Ipatova, O M: 6 articles (03/2015 - 01/2000)
2.	Torkhovskaia, T I: 5 articles (03/2009 - 01/2000)
3.	Archakov, A I: 4 articles (09/2003 - 01/2000)
4.	Tikhonova, E G: 3 articles (03/2015 - 01/2000)
5.	Kniazhev, V A: 3 articles (03/2002 - 01/2000)
6.	Kovalev, O B: 2 articles (01/2000 - 01/2000)
7.	Uchaĭkin, V F: 2 articles (01/2000 - 01/2000)
8.	Grishkina, N A: 1 article (01/2018)
9.	Riasenskii, D S: 1 article (01/2018)
10.	Bushmina, O N: 1 article (11/2017)

Related Diseases

1.	Psoriatic Arthritis 09/01/2003 - "The results show that Phosphogliv inclusion into therapy improved the state of patients with psoriatic arthritis. " 09/01/2003 - "[Hemorheological and clinical efficiency of a new phospholipid hepatoprotective drug Phosphogliv in patients with psoriatic arthritis]."
2.	Pulmonary Tuberculosis 01/01/2018 - "The study included 356 patients with pulmonary tuberculosis of young and middle age, out of which 308 patients received etiotropic chemotherapy without the administration of phosphogliv, and 48 patients receiving comprehensive treatment used a combined scheme of oral-parenteral administration of phosphogliv. "
3.	Hepatitis 03/01/2002 - "Their selected combination in Phosphogliv provided its high efficiency in rat hepatitis models. " 03/01/2015 - "Being developed at IBMC for the treatment of liver diseases, including viral hepatitis, Phosphogliv (currently marketed by the "Pharmstandard" company) is approved for clinical application in 2000, and is widely used in medical practice. " 01/01/2000 - "Among biochemical hepatitis markers, serum bilirubin level was most responsive to phosphogliv. "
4.	Liver Diseases (Liver Disease) 03/01/2009 - "This suggests that the phosphogliv injection forms may be used not only for treatment of liver diseases, but also for delivery of a number of other drugs and consequently for optimization of their efficiency." 03/01/2015 - "Being developed at IBMC for the treatment of liver diseases, including viral hepatitis, Phosphogliv (currently marketed by the "Pharmstandard" company) is approved for clinical application in 2000, and is widely used in medical practice. "
5.	Non-alcoholic Fatty Liver Disease 01/01/2017 - "The effects of UDCA in the therapy of NAFLD and gallbladder abnormality in patients with progressive psoriasis were greater than those of phosphogliv. "

Related Drugs and Biologics

1.	Phospholipids (Phosphatides)
2.	Budesonide (Pulmicort)
3.	Glycyrrhizic Acid (Glycyrrhizin)
4.	Biomarkers (Surrogate Marker)
5.	Suspensions
6.	Salts
7.	Powders
8.	Doxorubicin (Adriamycin)
9.	Bilirubin
10.	Antigens

Related Therapies and Procedures

1.	Therapeutics
2.	Drug Therapy (Chemotherapy)